COVID-19 and type 2 diabetes: do shared pathways have therapeutic implications?

During a special COVID-19 session at this year's online Annual Meeting of the European Association for the Study of Diabetes (EASD), Prof. Daniel J. Drucker (Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Canada) will present a new review the latest clinical findings linking diabetes to risk of infection and differential outcomes in people with COVID-19 infection.